Macquarie Home | Course Handbook | Library | Campus Map | Macquarie Contacts
Home page

Macquarie University ResearchOnline

Home
Add
-List Of Titles -Vasostatin I (CgA(₁₇-₇₆)) vasoconstricts rat splanchnic vascular bed but does not affect central cardiovascular function

Please use this identifier to cite or link to this item: http://hdl.handle.net/1959.14/150339

OpenURL Link
32 Visitors 39 Hits 0 Downloads
Title
Vasostatin I (CgA(₁₇-₇₆)) vasoconstricts rat splanchnic vascular bed but does not affect central cardiovascular function
Related
Autonomic neuroscience : basic & clinical, Vol. 166, Issue 1-2, (2012), p.22-28
DOI
10.1016/j.autneu.2011.08.023
Publisher
Elsevier
Date
2012
Author/Creator
Rahman, Ahmed A
Author/Creator
Shahid, Israt Z
Author/Creator
Fong, Angelina Y
Author/Creator
Hammond, Andrew M
Author/Creator
Pilowsky, Paul M
Description
Vasostatin I (CgA₁₇-₇₆) is a naturally occurring biologically active peptide derived from chromogranin A (CgA), and is so named for its inhibitory effects on vascular tension. CgA mRNA is expressed abundantly in sympathoexcitatory catecholaminergic neurons of the rostral ventrolateral medulla (RVLM). CgA microinjection into the RVLM decreases blood pressure (BP), heart rate (HR) and sympathetic nerve activity (SNA). Proteolytic fragments of CgA are thought to be responsible for the cardiovascular effects observed. We hypothesised that vasostatin I is one of the fragments responsible for the central effects of CgA. We examined the role of a vasostatin I fragment, CgA₁₇-₇₆ (VS-I(CgA₁₇-₇₆)), containing the portion important for biological effects. The effects of VS-I(CgA₁₇-₇₆) delivered by intrathecal injection, or microinjection into the RVLM, on cardio-respiratory function in urethane anaesthetised, vagotomised, mechanically ventilated Sprague-Dawley rats (n = 21) were evaluated. The effects of intrathecal VS-I(CgA₁₇-₇₆) on the somato-sympathetic, baroreceptor and peripheral chemoreceptor reflexes were also examined. At the concentrations used (10, 100 or 200 μM, intrathecal; or 5 μM, RVLM microinjection) VS-I(CgA₁₇-₇₆) produced no change in mean arterial pressure, HR, splanchnic SNA, phrenic nerve amplitude or phrenic nerve frequency. All reflexes examined were unchanged following intrathecal VS-I(CgA₁₇-₇₆). In the periphery, VS-I(CgA₁₇-₇₆) potentiated the contractile effects of noradrenaline on rat mesenteric arteries (n = 6), with a significant left-shift in the dose response curve to noradrenaline (3.7 × 10⁻⁷ vs 7.7 × 10⁻⁷). Our results indicate that VS-I(CgA₁₇-₇₆) is active in the periphery but not centrally, and is not a central modulator of cardiorespiratory function and physiological reflexes.
Description
7 page(s)
Subject Keyword
Phrenic nerve discharge
Subject Keyword
Rat mesenteric artery
Subject Keyword
Reflex
Subject Keyword
Sympathetic nerve activity
Subject Keyword
Vasostatin I
Resource Type
journal article
Organisation
Macquarie University. Australian School of Advanced Medicine

Identifier
http://hdl.handle.net/1959.14/150339
Identifier
ISSN:1566-0702
Identifier
mq_res-20111121-151712
Language
eng
Reviewed
Reviewed
Save/E-mail Citation
Citation Format
E-mail Address
Subject
"Autonomic neuroscience : basic & clinical"
 
OR
  • Show All  
  • Show My Selections 
Advanced Search

Search

Rat mesenteric artery
Rahman, Ahmed A
Pilowsky, Paul M

Browse

  • By Title 
  • By Author/Creator 
  • By Department/Centre 
  • By Subject Keyword 
  • By Journal/Conference 
  • By FoR/RFCD codes 
  • By Resource Type 
  • By Date 

Highlights

  • Most Accessed Objects 
  • Recent Additions 
  • Pending Publications 
  • Author Profiles 

Resources

  • About ResearchOnline 
  • FAQ 
  • Open Access 
  • Open Access-FAQs 
  • Copyright 
  • Contribute 
  • Help 
  • Contact
  • Terms and Conditions 
Valid XHTML 1.0 Strict Powered by VITAL

Copyright Macquarie University | Privacy Statement | Accessibility Information

ABN 90 952 801 237 | CRICOS Provider No 00002J

Library Staff Sign In